High-dose antioxidants for central serous chorioretinopathy; The randomized placebo-controlled study

BACKGROUND: To determine the efficacy of high-dose antioxidants in the acute stage of central serous chorioretinopathy (CSC). METHODS: This was a randomized placebo-controlled study. The patients with acute CSC (onset within 6 weeks) were randomized to receive either high-dose antioxidant tablets (s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratanasukon, Mansing, Bhurayanontachai, Patama, Jirarattanasopa, Pichai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410804/
https://www.ncbi.nlm.nih.gov/pubmed/22800086
http://dx.doi.org/10.1186/1471-2415-12-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410804/
https://www.ncbi.nlm.nih.gov/pubmed/22800086
http://dx.doi.org/10.1186/1471-2415-12-20

Ejemplares similares